198
Views
15
CrossRef citations to date
0
Altmetric
Drug Evaluation

Valproate semisodium ER for migraine and cluster headache prophylaxis

, DMD (Headache Fellow) & , MD (Assistant Professor of Neurology)
Pages 495-504 | Published online: 19 Mar 2010
 

Abstract

Importance of the field: Migraine and cluster headache (CH) are disabling syndromes that often require prophylactic treatment. Valproate semisodium ER (VPS ER) is FDA-approved for the treatment of epilepsy, acute mania in bipolar disorder and migraine prophylaxis.

Areas covered in this review: We reviewed literature regarding VPS ER pharmacokinetics and its use in migraine and CH prophylaxis.

What the reader will gain: VPS ER is well studied and effective in the preventive treatment of migraine and CH. This article reviews the evidence for its use, describes how to administer and dose this medication, and reviews important safety precautions.

Take home message: VPS ER is effective in the prophylactic treatment of migraine and CH. This once-a-day dosing formulation may increase compliance.

Acknowledgements

The authors thank SD Silberstein and L Kaiser for editing the article.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.